Literature DB >> 16164581

B-type natriuretic peptide for risk stratification in community-acquired pneumonia.

C Mueller, K Laule-Kilian, A Scholer, A P Perruchoud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16164581     DOI： 10.1111/j.1365-2796.2005.01540.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  8 in total

1.  Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study.

Authors:  Kun Xiao; Long-Xiang Su; Bing-Chao Han; Peng Yan; Na Yuan; Jie Deng; Jia Li; Li-Xin Xie
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  B-type natriuretic peptide in predicting the severity of community-acquired pneumonia.

Authors:  Jing Li; Huan Ye; Li Zhao
Journal:  World J Emerg Med       Date:  2015

Review 3.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Jana Papassotiriou; Reinhard Marre; Klaus Richter; Christian Schumann; Heike von Baum; Nils G Morgenthaler; Norbert Suttorp; Tobias Welte
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

5.  Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Authors:  Philipp Schuetz; Marcel Wolbers; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Nils G Morgenthaler; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  Crit Care       Date:  2010-06-08       Impact factor: 9.097

6.  Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Marcel Wolbers; Ursula Schild; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Claudine A Blum; Ronald Schönenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Müller
Journal:  BMC Health Serv Res       Date:  2007-07-05       Impact factor: 2.655

7.  Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

Authors:  Philipp Schuetz; Daiana Stolz; Beat Mueller; Nils G Morgenthaler; Joachim Struck; Christian Mueller; Roland Bingisser; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2008-02-28       Impact factor: 3.090

Review 8.  New markers in pneumonia.

Authors:  Chao-Wen Cheng; Ming-Hsien Chien; Shih-Chi Su; Shun-Fa Yang
Journal:  Clin Chim Acta       Date:  2013-02-04       Impact factor: 3.786
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.